Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Total Current Liabilities (2023 - 2025)

Camp4 Therapeutics (CAMP) has disclosed Total Current Liabilities for 3 consecutive years, with $15.5 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities rose 61.64% to $15.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $15.5 million through Dec 2025, up 61.64% year-over-year, with the annual reading at $15.5 million for FY2025, 61.64% up from the prior year.
  • Total Current Liabilities hit $15.5 million in Q4 2025 for Camp4 Therapeutics, up from $7.9 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $15.5 million in Q4 2025 to a low of $6.4 million in Q1 2025.
  • Historically, Total Current Liabilities has averaged $9.5 million across 3 years, with a median of $7.9 million in 2025.
  • Biggest YoY gain for Total Current Liabilities was 61.64% in 2025; the steepest drop was 33.19% in 2025.
  • Year by year, Total Current Liabilities stood at $7.8 million in 2023, then increased by 22.94% to $9.6 million in 2024, then skyrocketed by 61.64% to $15.5 million in 2025.
  • Business Quant data shows Total Current Liabilities for CAMP at $15.5 million in Q4 2025, $7.9 million in Q3 2025, and $7.3 million in Q2 2025.